Hexagon Capital Partners LLC Charles River Laboratories International, Inc. Transaction History

Hexagon Capital Partners LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 18, 2024	SELL	$203.52 - $273.43 $1,628 - $2,187	-8 Reduced 66.67%	4 $1,000
Q1 2023 Apr 24, 2023	SELL	$191.89 - $259.92 $3,645 - $4,938	-19 Reduced 61.29%	12 $2,000
Q3 2022 Oct 17, 2022	BUY	$182.44 - $250.54 $1,094 - $1,503	6 Added 24.0%	31 $6,000
Q2 2021 Aug 11, 2021	SELL	$294.17 - $371.65 $4,412 - $5,574	-15 Reduced 37.5%	25 $9,000
Q1 2021 May 13, 2021	SELL	$249.67 - $299.48 $1,498 - $1,796	-6 Reduced 13.04%	40 $11,000
Q3 2020 Nov 10, 2020	BUY	$175.56 - $226.45 $8,075 - $10,416	46 New	46 $10,000

696

52.3M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.56B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Hexagon Capital Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Hexagon Capital Partners LLC with notifications on news.